Creative Medical Technology Holdings, Inc. Accrued Liabilities, Current
Creative Medical Technology Holdings, Inc. (CELZ) had Accrued Liabilities, Current of $0 as of 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-03-20
- 2025-12-31: Accrued Liabilities, Current $0.00.
- 2025-09-30: Accrued Liabilities, Current $0.00.
- 2025-06-30: Accrued Liabilities, Current $0.00.
- 2025-03-31: Accrued Liabilities, Current $0.00.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-20 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-08 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 |
| 2024-12-31 | $39.92K 10-K · filed 2026-03-20 |
| 2024-09-30 | $42.92K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $39.92K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $39.92K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $39.92K 10-K · filed 2025-03-14 |
| 2023-09-30 | $39.92K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $39.92K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $39.92K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $39.92K 10-K · filed 2024-03-22 |
| 2022-09-30 | $54.92K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $64.92K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $29.92K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $24.39K 10-K · filed 2023-03-31 |
| 2021-09-30 | $29.92K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $71.47K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $67.76K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $159.77K 10-K · filed 2022-03-30 |
| 2020-09-30 | $155.57K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $158.07K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $137.57K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $120.49K 10-K · filed 2021-03-17 |
| 2019-09-30 | $65.28K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $91.20K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $69.59K 10-Q · filed 2019-05-20 |
| 2018-12-31 | $21.64K 10-K · filed 2020-04-06 |
| 2018-09-30 | $29.64K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $40.05K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $25.24K 10-Q · filed 2018-08-03 |
| 2017-12-31 | $23.14K 10-K · filed 2019-04-01 |
| 2017-09-30 | $14.46K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $9.87K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $6.89K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $4.88K 10-K · filed 2018-03-29 |
| 2016-09-30 | $2.82K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $2.74K 10-Q · filed 2016-08-19 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |